These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 38932228)

  • 1. Protein Nanoparticles as Vaccine Platforms for Human and Zoonotic Viruses.
    Pandey KK; Sahoo BR; Pattnaik AK
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advancements in protein nanoparticle vaccine platforms to combat infectious disease.
    Butkovich N; Li E; Ramirez A; Burkhardt AM; Wang SW
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 May; 13(3):e1681. PubMed ID: 33164326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic Modifications of Icosahedral Plant Virus-based Nanoparticles for Vaccine and Immunotherapy Applications.
    Narayanan KB; Han SS
    Curr Protein Pept Sci; 2017 Aug; 18(11):1141-1151. PubMed ID: 28440187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design.
    Plummer EM; Manchester M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2011; 3(2):174-196. PubMed ID: 20872839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant viruses as vaccines against viral diseases.
    Souza AP; Haut L; Reyes-Sandoval A; Pinto AR
    Braz J Med Biol Res; 2005 Apr; 38(4):509-22. PubMed ID: 15962176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming Cross-Protective Bovine Viral Diarrhea Virus-Specific Immunity Using Live-Vectored Mosaic Antigens.
    Lokhandwala S; Fang X; Waghela SD; Bray J; Njongmeta LM; Herring A; Abdelsalam KW; Chase C; Mwangi W
    PLoS One; 2017; 12(1):e0170425. PubMed ID: 28099492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New viral vectors for infectious diseases and cancer.
    Sasso E; D'Alise AM; Zambrano N; Scarselli E; Folgori A; Nicosia A
    Semin Immunol; 2020 Aug; 50():101430. PubMed ID: 33262065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virus like particle-based vaccines against emerging infectious disease viruses.
    Liu J; Dai S; Wang M; Hu Z; Wang H; Deng F
    Virol Sin; 2016 Aug; 31(4):279-87. PubMed ID: 27405928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel vaccine strategies against emerging viruses.
    García-Sastre A; Mena I
    Curr Opin Virol; 2013 Apr; 3(2):210-6. PubMed ID: 23477832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Pre-Existing Antibodies on Live-Attenuated Viral Vaccines.
    Mok DZL; Chan KR
    Viruses; 2020 May; 12(5):. PubMed ID: 32397218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoparticle-based vaccine development and evaluation against viral infections in pigs.
    Dhakal S; Renukaradhya GJ
    Vet Res; 2019 Nov; 50(1):90. PubMed ID: 31694705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of EV71 vaccine candidates.
    Chong P; Hsieh SY; Liu CC; Chou AH; Chang JY; Wu SC; Liu SJ; Chow YH; Su IJ; Klein M
    Hum Vaccin Immunother; 2012 Dec; 8(12):1775-83. PubMed ID: 22992566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-like particles as immunogens.
    Noad R; Roy P
    Trends Microbiol; 2003 Sep; 11(9):438-44. PubMed ID: 13678860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine technologies: From whole organisms to rationally designed protein assemblies.
    Karch CP; Burkhard P
    Biochem Pharmacol; 2016 Nov; 120():1-14. PubMed ID: 27157411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design.
    Nguyen QD; Kikuchi K; Maity B; Ueno T
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA vaccines: developing new strategies to enhance immune responses.
    Abdulhaqq SA; Weiner DB
    Immunol Res; 2008; 42(1-3):219-32. PubMed ID: 19066740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.
    Rocha CD; Caetano BC; Machado AV; Bruna-Romero O
    Int Microbiol; 2004 Jun; 7(2):83-94. PubMed ID: 15248156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens.
    Ueda G; Antanasijevic A; Fallas JA; Sheffler W; Copps J; Ellis D; Hutchinson GB; Moyer A; Yasmeen A; Tsybovsky Y; Park YJ; Bick MJ; Sankaran B; Gillespie RA; Brouwer PJ; Zwart PH; Veesler D; Kanekiyo M; Graham BS; Sanders RW; Moore JP; Klasse PJ; Ward AB; King NP; Baker D
    Elife; 2020 Aug; 9():. PubMed ID: 32748788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide vaccines for viral diseases.
    Francis MJ
    Sci Prog; 1990; 74(293 Pt 1):115-30. PubMed ID: 2267573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comprehensive Review of Our Understanding and Challenges of Viral Vaccines against Swine Pathogens.
    Kamboj A; Dumka S; Saxena MK; Singh Y; Kaur BP; da Silva SJR; Kumar S
    Viruses; 2024 May; 16(6):. PubMed ID: 38932126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.